Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Alagille Syndrome

• A Study of TAK-625 for the Treatment of Alagille Syndrome (ALGS)
• Atorvastatin Therapy on Xanthoma in Alagille Syndrome
• Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome
• A Study to Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS).
• Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome
• A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384
• Safety and Efficacy Study of LUM001 (Maralixibat) With a Drug Withdrawal Period in Participants With Alagille Syndrome (ALGS)
• An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Pediatric Subjects With Alagille Syndrome
• Evaluation of LUM001 in the Reduction of Pruritus in Alagille Syndrome
• An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Subjects With Alagille Syndrome (ALGS)
• Safety and Efficacy Study of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Alagille Syndrome
• Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease